1. Home
  2. MREO vs HVT Comparison

MREO vs HVT Comparison

Compare MREO & HVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • HVT
  • Stock Information
  • Founded
  • MREO 2015
  • HVT 1885
  • Country
  • MREO United Kingdom
  • HVT United States
  • Employees
  • MREO N/A
  • HVT N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • HVT Other Specialty Stores
  • Sector
  • MREO Health Care
  • HVT Consumer Discretionary
  • Exchange
  • MREO Nasdaq
  • HVT Nasdaq
  • Market Cap
  • MREO 369.2M
  • HVT 336.0M
  • IPO Year
  • MREO N/A
  • HVT N/A
  • Fundamental
  • Price
  • MREO $2.26
  • HVT $19.73
  • Analyst Decision
  • MREO Strong Buy
  • HVT Strong Buy
  • Analyst Count
  • MREO 7
  • HVT 1
  • Target Price
  • MREO $7.71
  • HVT $45.00
  • AVG Volume (30 Days)
  • MREO 1.2M
  • HVT 176.1K
  • Earning Date
  • MREO 03-26-2025
  • HVT 04-30-2025
  • Dividend Yield
  • MREO N/A
  • HVT 6.49%
  • EPS Growth
  • MREO N/A
  • HVT N/A
  • EPS
  • MREO N/A
  • HVT 1.19
  • Revenue
  • MREO N/A
  • HVT $722,899,000.00
  • Revenue This Year
  • MREO N/A
  • HVT $5.31
  • Revenue Next Year
  • MREO $69.09
  • HVT $8.06
  • P/E Ratio
  • MREO N/A
  • HVT $16.99
  • Revenue Growth
  • MREO N/A
  • HVT N/A
  • 52 Week Low
  • MREO $2.16
  • HVT $19.57
  • 52 Week High
  • MREO $5.02
  • HVT $33.97
  • Technical
  • Relative Strength Index (RSI)
  • MREO 33.19
  • HVT 36.02
  • Support Level
  • MREO $2.23
  • HVT $20.76
  • Resistance Level
  • MREO $2.73
  • HVT $20.86
  • Average True Range (ATR)
  • MREO 0.14
  • HVT 0.71
  • MACD
  • MREO -0.01
  • HVT -0.15
  • Stochastic Oscillator
  • MREO 7.89
  • HVT 5.97

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About HVT Haverty Furniture Companies Inc.

Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.

Share on Social Networks: